- Home
- OSBC vs RLAY Comparison
OSBC vs RLAY Comparison
Compare OSBC & RLAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OSBC
- RLAY
- Stock Information
- Founded
- OSBC 1981
- RLAY 2015
- Country
- OSBC United States
- RLAY United States
- Employees
- OSBC N/A
- RLAY N/A
- Industry
- OSBC Major Banks
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- OSBC Finance
- RLAY Health Care
- Exchange
- OSBC Nasdaq
- RLAY Nasdaq
- Market Cap
- OSBC 860.4M
- RLAY 811.8M
- IPO Year
- OSBC N/A
- RLAY 2020
- Fundamental
- Price
- OSBC $18.33
- RLAY $3.92
- Analyst Decision
- OSBC Buy
- RLAY Strong Buy
- Analyst Count
- OSBC 4
- RLAY 10
- Target Price
- OSBC $19.75
- RLAY $20.11
- AVG Volume (30 Days)
- OSBC 210.5K
- RLAY 1.5M
- Earning Date
- OSBC 04-16-2025
- RLAY 02-28-2025
- Dividend Yield
- OSBC 1.31%
- RLAY N/A
- EPS Growth
- OSBC N/A
- RLAY N/A
- EPS
- OSBC 1.87
- RLAY N/A
- Revenue
- OSBC $272,704,000.00
- RLAY $10,006,000.00
- Revenue This Year
- OSBC N/A
- RLAY N/A
- Revenue Next Year
- OSBC $1.54
- RLAY N/A
- P/E Ratio
- OSBC $9.80
- RLAY N/A
- Revenue Growth
- OSBC 1.15
- RLAY N/A
- 52 Week Low
- OSBC $13.00
- RLAY $3.50
- 52 Week High
- OSBC $19.46
- RLAY $10.79
- Technical
- Relative Strength Index (RSI)
- OSBC 43.67
- RLAY 41.60
- Support Level
- OSBC $17.68
- RLAY $3.85
- Resistance Level
- OSBC $19.06
- RLAY $4.19
- Average True Range (ATR)
- OSBC 0.60
- RLAY 0.28
- MACD
- OSBC -0.09
- RLAY -0.02
- Stochastic Oscillator
- OSBC 36.52
- RLAY 24.80
About OSBC Old Second Bancorp Inc.
Old Second Bancorp Inc is a bank holding company. It provides consumer and commercial banking products such as demand, money market, savings, time deposit, and individual retirement as well as commercial, industrial, consumer, and real estate lending, including installment loans, student loans, agricultural loans, lines of credit and overdraft checking, safe deposit operations, trust services, wealth management services, and additional services tailored to the needs of individual customers, corporates, small-medium enterprises. The company's revenue consists of interest, commission, payments, and other income.
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).